Northwest Biotherapeutics (OTCMKTS:NWBO) Hits New 52-Week Low at $0.40

Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO) shares hit a new 52-week low during trading on Monday . The company traded as low as $0.40 and last traded at $0.41, with a volume of 3791105 shares. The stock had previously closed at $0.43.

Northwest Biotherapeutics Stock Up 0.5 %

The stock has a market cap of $512.59 million, a PE ratio of -6.00 and a beta of -0.57. The business has a 50 day moving average price of $0.46 and a 200 day moving average price of $0.54.

Northwest Biotherapeutics (OTCMKTS:NWBO) last released its quarterly earnings results on Friday, May 10th. The biotechnology company reported ($0.02) earnings per share for the quarter. The company had revenue of $0.28 million during the quarter.

Northwest Biotherapeutics Company Profile

Northwest Biotherapeutics, Inc, a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer.